Mutual Of America Capital Management LLC Sage Therapeutics, Inc. Transaction History

Mutual Of America Capital Management LLC

$9.18 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$27.52 - $37.99 $625,969 - $864,120	-22,746 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$30.71 - $45.71 $30,310 - $45,115	-987 Reduced 4.16%	22,746 $753,000
Q4 2021 Feb 03, 2022	SELL	$37.06 - $47.11 $8,190 - $10,411	-221 Reduced 0.92%	23,733 $1.01 Million
Q3 2021 Nov 10, 2021	SELL	$40.26 - $57.37 $84,586 - $120,534	-2,101 Reduced 8.06%	23,954 $1.06 Million
Q2 2021 Aug 06, 2021	SELL	$54.88 - $79.29 $64,758 - $93,562	-1,180 Reduced 4.33%	26,055 $1.48 Million

Q1 2021 May 13, 2021	SELL	$70.65 - $96.76 $102,866 - $140,882	-1,456 Reduced 5.07%	27,235 $2.04 Million
Q4 2020 Feb 12, 2021	SELL	$58.41 - $89.06 $38,842 - $59,224	-665 Reduced 2.27%	28,691 $2.48 Million
Q3 2020 Nov 13, 2020	SELL	$41.13 - $62.45 $192,488 - $292,266	-4,680 Reduced 13.75%	29,356 $1.79 Million
Q2 2020 Aug 06, 2020	BUY	$25.95 - $43.15 $270,399 - $449,623	10,420 Added 44.12%	34,036 $1.42 Million
Q1 2020 May 11, 2020	BUY	$26.15 - $77.24 $1,019 - $3,012	39 Added 0.17%	23,616 $678,000
Q4 2019 Feb 11, 2020	BUY	$60.18 - $154.77 $617,085 - $1.59 Million	10,254 Added 76.96%	23,577 $1.7 Million
Q3 2019 Nov 14, 2019	SELL	$140.29 - $189.96 $394,214 - $533,787	-2,810 Reduced 17.42%	13,323 $1.87 Million
Q2 2019 Aug 12, 2019	BUY	$157.85 - $183.09 $1,578 - $1,830	10 Added 0.06%	16,133 $2.95 Million
Q1 2019 May 13, 2019	BUY	$89.33 - $163.65 $25,637 - $46,967	287 Added 1.81%	16,123 $2.56 Million
Q3 2018 Nov 13, 2018	SELL	$138.11 - $169.04 $1.27 Million - $1.56 Million	-9,214 Reduced 36.78%	15,836 $2.24 Million
Q2 2018 Aug 09, 2018	SELL	$140.36 - $175.76 $1.43 Million - $1.79 Million	-10,165 Reduced 28.87%	25,050 $3.92 Million
Q1 2018 May 11, 2018	SELL	$152.15 - $192.33 $22,822 - $28,849	-150 Reduced 0.42%	35,215 $5.67 Million
Q4 2017 Jan 31, 2018	SELL	$60.72 - $167.34 $120,286 - $331,500	-1,981 Reduced 5.3%	35,365 $5.83 Million
Q3 2017 Oct 18, 2017	BUY	$61.4 - $88.52 $2.29 Million - $3.31 Million	37,346	37,346 $2.33 Million

Others Institutions Holding SAGE

# of Institutions

220

Shares Held

52.7M

Call Options Held

207K

Put Options Held

191K

Vanguard Group Inc Valley Forge, PA

5.75M
Shares

$70.7 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.48M
Shares

$67.4 Million
1.65% of portfolio
Black Rock Inc. New York, NY

4.89M
Shares

$60.1 Million
0.0% of portfolio
Wellington Management Group LLP Boston, MA

4.75M
Shares

$58.4 Million
0.02% of portfolio
State Street Corp Boston, MA

4.49M
Shares

$55.2 Million
0.0% of portfolio

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $730M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.

Account